Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker CRL
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Oct 22, 2026 | James C. Foster Director | CRL Charles River Laboratories International, Inc. | 24,042 | $8.4M | 10b5-1 | Oct 22, 2026 | Form 4 ↗ 4 days later · 24,042 shares | Form 144 ↗ |
| Oct 21, 2026 | Shannon M. Parisotto Officer | CRL Charles River Laboratories International, Inc. | 2,156 | $742.5K | 10b5-1 | Oct 21, 2026 | Form 4 ↗ 2 days later · 2,156 shares | Form 144 ↗ |
| Oct 5, 2026 | Shannon M. Parisotto Officer | CRL Charles River Laboratories International, Inc. | 981 | $308.6K | 10b5-1 | Oct 5, 2026 | Form 4 ↗ 18 days later · 2,156 shares | Form 144 ↗ |
| Aug 25, 2026 | James C. Foster Director | CRL Charles River Laboratories International, Inc. | 33,561 | $10.1M | 10b5-1 | Aug 25, 2026 | Form 4 ↗ 2 days later · 33,561 shares | Form 144 ↗ |
| Aug 19, 2026 | Shannon M. Parisotto Officer | CRL Charles River Laboratories International, Inc. | 2,039 | $599.7K | 10b5-1 | Aug 19, 2026 | Form 4 ↗ 1 day later · 2,039 shares | Form 144 ↗ |
| Aug 18, 2026 | Nancy C Andrews Director | CRL Charles River Laboratories International, Inc. | 573 | $163.3K | — | Aug 18, 2026 | Form 4 ↗ 2 days later · 573 shares | Form 144 ↗ |
| Aug 11, 2026 | Shannon M. Parisotto Officer | CRL Charles River Laboratories International, Inc. | 3,714 | $1.0M | 10b5-1 | Aug 11, 2026 | Form 4 ↗ 2 days later · 3,714 shares | Form 144 ↗ |
| Aug 11, 2026 | Girshick Birgit Officer, CEO & President | CRL Charles River Laboratories International, Inc. | 6,500 | $1.8M | 10b5-1 | Aug 11, 2026 | Form 4 ↗ 2 days later · 6,500 shares | Form 144 ↗ |
| Aug 10, 2026 | James C. Foster Director | CRL Charles River Laboratories International, Inc. | 28,733 | $7.9M | 10b5-1 | Aug 10, 2026 | Form 4 ↗ 1 day later · 28,733 shares | Form 144 ↗ |
| Aug 6, 2026 | Victoria Creamer Officer | CRL Charles River Laboratories International, Inc. | 4,179 | $1.1M | — | Aug 6, 2026 | Form 4 ↗ 4 days later · 4,179 shares | Form 144 ↗ |
| Aug 6, 2026 | Michael Knell Officer | CRL Charles River Laboratories International, Inc. | 6,645 | $1.7M | — | Aug 6, 2026 | Form 4 ↗ 4 days later · 6,645 shares | Form 144 ↗ |
| Aug 5, 2026 | Shannon M. Parisotto Officer | CRL Charles River Laboratories International, Inc. | 5,046 | $1.3M | 10b5-1 | Aug 5, 2026 | Form 4 ↗ 1 day later · 5,046 shares | Form 144 ↗ |
| Jun 29, 2026 | James C. Foster Director | CRL Charles River Laboratories International, Inc. | 75,000 | $16.9M | 10b5-1 | Jun 29, 2026 | Form 4 ↗ 2 days later · 75,000 shares | Form 144 ↗ |
| Aug 22, 2025 | Joseph LaPlume Officer | CRL Charles River Laboratories International, Inc. | 400 | $61.0K | — | Aug 22, 2025 | — | Form 144 ↗ |
| Aug 18, 2025 | Joseph LaPlume Officer | CRL Charles River Laboratories International, Inc. | 800 | $125.6K | — | Aug 18, 2025 | Form 4 ↗ 2 days later · 800 shares | Form 144 ↗ |
| Aug 18, 2025 | Richard F. Wallman Former Director | CRL Charles River Laboratories International, Inc. | 22,500 | $3.4M | — | Aug 18, 2025 | — | Form 144 ↗ |
| Aug 7, 2025 | Joseph LaPlume Officer | CRL Charles River Laboratories International, Inc. | 400 | $60.0K | — | Aug 7, 2025 | Form 4 ↗ 1 day later · 400 shares | Form 144 ↗ |
| Jul 21, 2025 | Richard F. Wallman Former Director | CRL Charles River Laboratories International, Inc. | 8,500 | $1.3M | — | Jul 21, 2025 | — | Form 144 ↗ |
| Jun 25, 2025 | Richard F. Wallman Former Director | CRL Charles River Laboratories International, Inc. | 4,000 | $550.0K | — | Jun 23, 2025 | — | Form 144 ↗ |
| May 14, 2025 | George Massaro Director | CRL Charles River Laboratories International, Inc. | 280 | $39.4K | 10b5-1 | May 14, 2025 | Form 4 ↗ 1 day later · 140 shares | Form 144 ↗ |
| May 13, 2025 | Joseph LaPlume Officer | CRL Charles River Laboratories International, Inc. | 500 | $72.2K | — | May 13, 2025 | Form 4 ↗ 2 days later · 500 shares | Form 144 ↗ |
| Feb 20, 2025 | Joseph LaPlume Officer | CRL Charles River Laboratories International, Inc. | 4,400 | $726.0K | — | Feb 20, 2025 | Form 4 ↗ 1 day later · 4,400 shares | Form 144 ↗ |
| Nov 7, 2024 | Richard F. Wallman Director | CRL Charles River Laboratories International, Inc. | 12,161 | $2.6M | — | Nov 7, 2024 | Form 4 ↗ 5 days later · 7,621 shares | Form 144 ↗ |
| Aug 8, 2024 | Joseph LaPlume Officer | CRL Charles River Laboratories International, Inc. | 1,780 | $350.0K | — | Aug 8, 2024 | — | Form 144 ↗ |
| Aug 1, 2024 | James C. Foster Officer, Chairman, President , CEO | CRL Charles River Laboratories International, Inc. | 25,000 | $6.3M | 10b5-1 | Aug 1, 2024 | — | Form 144 ↗ |
| May 15, 2024 | George Massaro Director | CRL Charles River Laboratories International, Inc. | 332 | $78.4K | 10b5-1 | May 15, 2024 | — | Form 144 ↗ |
| May 10, 2024 | Joseph LaPlume Officer | CRL Charles River Laboratories International, Inc. | 1,304 | $300.0K | — | May 10, 2024 | — | Form 144 ↗ |
| Mar 8, 2024 | Michael Knell Officer | CRL Charles River Laboratories International, Inc. | 808 | $218.2K | — | Mar 8, 2024 | — | Form 144 ↗ |
| Mar 4, 2024 | Michael Knell Officer | CRL Charles River Laboratories International, Inc. | 2,750 | $726.0K | — | Mar 4, 2024 | — | Form 144 ↗ |
| Feb 29, 2024 | Victoria Creamer Officer | CRL Charles River Laboratories International, Inc. | 5,000 | $1.3M | — | Feb 29, 2024 | — | Form 144 ↗ |
| Feb 29, 2024 | Shannon Parisotto Officer | CRL Charles River Laboratories International, Inc. | 3,786 | $980.6K | — | Feb 29, 2024 | — | Form 144 ↗ |
| Feb 22, 2024 | Wiliam D. Barbo Revocable Trust of 2019 Officer | CRL Charles River Laboratories International, Inc. | 4,050 | $1.0M | — | Feb 22, 2024 | — | Form 144 ↗ |
| Feb 15, 2024 | Shannon M. Parisotto Officer | CRL Charles River Laboratories International, Inc. | 5,882 | $1.4M | 10b5-1 | Feb 15, 2024 | — | Form 144 ↗ |
| Feb 15, 2024 | Joseph LaPlume Officer | CRL Charles River Laboratories International, Inc. | 838 | $201.1K | — | Feb 15, 2024 | — | Form 144 ↗ |
| Dec 14, 2023 | Victoria L. Creamer Officer | CRL Charles River Laboratories International, Inc. | 5,526 | $1.2M | 10b5-1 | Dec 14, 2023 | — | Form 144 ↗ |
| Nov 30, 2023 | Joseph LaPlume Officer | CRL Charles River Laboratories International, Inc. | 1,850 | $361.7K | — | Nov 30, 2023 | — | Form 144 ↗ |
| Nov 9, 2023 | Joseph LaPlume Officer | CRL Charles River Laboratories International, Inc. | 9,128 | $1.6M | — | Nov 9, 2023 | — | Form 144 ↗ |
| Aug 10, 2023 | William Barbo Officer | CRL Charles River Laboratories International, Inc. | 5,763 | $1.2M | — | Aug 10, 2023 | — | Form 144 ↗ |
| Aug 10, 2023 | Michael Knell Officer | CRL Charles River Laboratories International, Inc. | 1,471 | $316.3K | — | Aug 10, 2023 | — | Form 144 ↗ |
| Aug 10, 2023 | Joseph LaPlume Officer | CRL Charles River Laboratories International, Inc. | 700 | $150.5K | — | Aug 10, 2023 | — | Form 144 ↗ |
| May 15, 2023 | Joseph LaPlume Officer | CRL Charles River Laboratories International, Inc. | 345 | $65.5K | — | May 15, 2023 | — | Form 144 ↗ |
| May 12, 2023 | Joseph LaPlume Officer | CRL Charles River Laboratories International, Inc. | 959 | $185.1K | — | May 12, 2023 | — | Form 144 ↗ |
| May 11, 2023 | George Massaro Director | CRL Charles River Laboratories International, Inc. | 288 | $54.5K | 10b5-1 | May 11, 2023 | — | Form 144 ↗ |
43 items, most recent first (up to 50). Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 6:50 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances